14290 Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–982] 

Bulk Manufacturer of Controlled 

Substances Application: Janssen 

Pharmaceuticals Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Janssen Pharmaceuticals Inc., 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTAL INFORMATION listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 13, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 13, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 10, 2021, 

Janssen Pharmaceuticals Inc., 1440 

Olympic Drive Athens, Georgia 30601– 

1645, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Methylphenidate ............. 1724 II 

Hydromorphone .............. 9150 II 

Hydrocodone .................. 9193 II 

Oripavine ........................ 9330 II 

Thebaine ......................... 9333 II 

Tapentadol ...................... 9780 II 

The company plans to manufacture 

the above-listed controlled substances 

in bulk for distribution to its customers. 

No other activities for these drug codes 

are authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05314 Filed 3–11–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–978] 

Bulk Manufacturer of Controlled 

Substances: ANI Pharmaceuticals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: ANI Pharmaceuticals, Inc., 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTAL INFORMATION listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 13, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 13, 2022. 

ADDRESSES: The DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on January 6, 2022, ANI 

Pharmaceuticals, Inc., 70 Lake Drive, 

East Windsor, New Jersey 08520, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ....................... 7437 I 

Psilocyn .......................... 7438 I 

Controlled substance Drug 

code Schedule 

Levorphanol .................... 9220 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use or for 

sale to its customers. No other activities 

for these drug codes are authorized for 

this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05323 Filed 3–11–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–976] 

Importer of Controlled Substances 

Application: Meridian Medical 

Technologies, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Meridian Medical 

Technologies, LLC, has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 13, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before April 13, 2022. 

ADDRESSES: The DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 14291 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 2, 2022, 

Meridian Medical Technologies, LLC, 

2555 Hermelin Drive, Saint Louis, 

Missouri 63144, applied to be registered 

as an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Morphine ......................... 9300 II 

The company plans to import the 

control substance for analytical and 

research purposes. No other activity for 

this drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05291 Filed 3–11–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–981] 

Importer of Controlled Substances 

Application: Sigma Aldrich Co. LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Co. LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 13, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before April 13, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 21, 2022, 

Sigma Aldrich Co. LLC, 3500 Dekalb 

Street, Saint Louis, Missouri 63118– 

4103, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug code Schedule 

Cathinone ............................................................................................................................................................................... 1235 I 

Methcathinone ........................................................................................................................................................................ 1237 I 

Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................... 1248 I 

Gamma Hydroxybutyric Acid .................................................................................................................................................. 2010 I 

Tetrahydrocannabinols ........................................................................................................................................................... 7370 I 

4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................. 7392 I 

2,5-Dimethoxyamphetamine ................................................................................................................................................... 7396 I 

3,4-Methylenedioxyamphetamine ........................................................................................................................................... 7400 I 

3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................. 7404 I 

3,4-Methylenedioxymethamphetamine ................................................................................................................................... 7405 I 

4-Methoxyamphetamine ......................................................................................................................................................... 7411 I 

Dimethyltryptamine ................................................................................................................................................................. 7435 I 

N-Benzylpiperazine ................................................................................................................................................................ 7493 I 

Heroin ..................................................................................................................................................................................... 9200 I 

Normorphine ........................................................................................................................................................................... 9313 I 

Amobarbital ............................................................................................................................................................................ 2125 II 

Secobarbital ............................................................................................................................................................................ 2315 II 

Nabilone ................................................................................................................................................................................. 7379 II 

Phencyclidine ......................................................................................................................................................................... 7471 II 

Ecgonine ................................................................................................................................................................................. 9180 II 

Ethylmorphine ......................................................................................................................................................................... 9190 II 

Levorphanol ............................................................................................................................................................................ 9220 II 

Meperidine .............................................................................................................................................................................. 9230 II 

Thebaine ................................................................................................................................................................................. 9333 II 

Opium, powdered ................................................................................................................................................................... 9639 II 

Levo-alphacetylmethadol ........................................................................................................................................................ 9648 II 


jspears on DSK121TN23PROD with NOTICES1